PLYX
Polaryx Therapeutics, Inc. Common Stock
NASDAQ: PLYX · HEALTHCARE · BIOTECHNOLOGY
$5.22
-7.28% today
Updated 2026-04-29
Market cap
$247.13M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-0.19
Dividend yield
—
52W range
$2 – $49
Volume
1.1M
Polaryx Therapeutics, Inc. Common Stock (PLYX) Financial statements
SEC filings — annual and quarterly data.
Profit margin
0.00%
Operating margin
0.00%
ROE
-193.70%
ROA
-96.10%
Debt/equity
—
Margin trends — annual
Gross margin Operating margin Profit margin
| Year | Revenue | Net income | Gross margin | Op. margin | Profit margin |
|---|---|---|---|---|---|
| 2023 | $0.00 | $-3.78M | — | — | — |
| 2024 | $0.00 | $-30.36M | — | — | — |
| 2025 | $0.00 | $-8.98M | — | — | — |